2014
DOI: 10.1007/s00592-014-0559-1
|View full text |Cite
|
Sign up to set email alerts
|

Atherosclerotic coronary plaque in subjects with diabetic neuropathy: the prognostic cardiovascular role of Charcot neuroarthropathy—a case–control study

Abstract: The aim of this study was to investigate the severity of coronary artery disease (CAD) and the plaque composition in neuropathic type 2 diabetic subjects with and without Charcot neuroarthropathy (CN) undergoing multidetector computed tomography coronary angiography (MDCT-CA). The study was a single-center, observational, with unmatched case-control design. We selected 17 CN patients and 18 patients with diabetic neuropathy (DN) without CN. In all the patients, multidetector computed tomography was performed t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
5
1

Year Published

2015
2015
2020
2020

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 40 publications
0
5
1
Order By: Relevance
“…Studies involving individuals with type 2 diabetes with a relatively short duration of disease also did not exhibit a relationship between CAC score and clinical neuropathy end points. In contrast, cardiac autonomic neuropathy was associated with CAC in participants with T1D who had a shorter duration of disease (mean duration 26 years) compared with participants in this study who had longer mean duration of disease (54 years) (23,24). To our knowledge, the current exploratory analysis suggests that both clinical and quantitative electrophysiological measures of neuropathy are associated with central atherosclerotic burden, as measured by CAC in the setting of long-standing T1D.…”
Section: Discussioncontrasting
confidence: 70%
“…Studies involving individuals with type 2 diabetes with a relatively short duration of disease also did not exhibit a relationship between CAC score and clinical neuropathy end points. In contrast, cardiac autonomic neuropathy was associated with CAC in participants with T1D who had a shorter duration of disease (mean duration 26 years) compared with participants in this study who had longer mean duration of disease (54 years) (23,24). To our knowledge, the current exploratory analysis suggests that both clinical and quantitative electrophysiological measures of neuropathy are associated with central atherosclerotic burden, as measured by CAC in the setting of long-standing T1D.…”
Section: Discussioncontrasting
confidence: 70%
“…Charcot neuroarthropathy (CN) is a diabetic complication involving bones, joints, and soft tissues of the foot and ankle, potentially leading to dislocations, fractures, and deformity and associated with an increased cardiovascular risk . The pathogenic mechanisms behind CN are still unclear, and its etiology is supposed to be multifactorial .…”
Section: Introductionmentioning
confidence: 99%
“…Our study shows that patients with CN have a higher prevalence of severe CAD in comparison with DN, but their coronary plaques did not exhibit an increased degree of calcium. Recently there has been described [41] an hypothesis which could explain this higher coronary plaque burden in CN, mainly linked to an over-expression of inflammation with production of several cytokines [tumour necrosis factor-α (TNF-α), interleukin-1 (IL-1)] [42] and determining an endothelial dysfunction by promoting the expression of procoagulant molecules, selectins, vascular cell adhesion protein-1 (VCAM-1), and the intercellular adhesion molecule-1 (ICAM-1) [43,44]. Furthermore, the lack of differences regarding the CACS might be a further confirmation that neuropathy is not the only factor in the pathogenesis of CN.…”
Section: Discussionmentioning
confidence: 99%